ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,912,393 | -22.6% | 457,654 | +0.4% | 0.02% | -20.8% |
| Q2 2022 | $12,804,360 | +4.0% | 455,684 | +70.8% | 0.02% | +41.2% |
| Q1 2022 | $12,309,753 | +9.8% | 266,786 | +100.0% | 0.02% | -41.4% |
| Q4 2021 | $11,213,000 | +27.7% | 133,392 | +1.2% | 0.03% | +16.0% |
| Q3 2021 | $8,783,000 | -35.0% | 131,801 | -48.1% | 0.02% | +31.6% |
| Q2 2021 | $13,506,000 | +89.8% | 253,890 | +54.8% | 0.02% | -13.6% |
| Q1 2021 | $7,116,000 | -14.9% | 164,012 | +1.9% | 0.02% | -15.4% |
| Q4 2020 | $8,361,000 | +63.9% | 160,970 | +3.1% | 0.03% | +44.4% |
| Q3 2020 | $5,102,000 | -50.2% | 156,087 | -26.8% | 0.02% | -10.0% |
| Q2 2020 | $10,242,000 | – | 213,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |